Showing results (51-60 of 5,446) with videos related to
Sort By:
Pageof 545
British Journal of Haematology|September 16, 2009
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trialMorie A Gertz, Rafat Abonour, Leonard T Heffner, et al.Leukemia|June 4, 2010
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myelomaS Kumar, L Zhang, A Dispenzieri, et al.Bone Marrow Transplantation|May 11, 2004
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapyS Kumar, M Q Lacy, A Dispenzieri, et al.Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.Leukemia|November 28, 2012
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myelomaJ T Larsen, S K Kumar, A Dispenzieri, et al.Leukemia|September 6, 2013
Relationship between initial clinical presentation and the molecular cytogenetic classification of myelomaA J Greenberg, S V Rajkumar, T M Therneau, et al.Leukemia|May 8, 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myelomaG Srivastava, V Rana, M Q Lacy, et al.International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade gliomaS V Rajkumar, J C Buckner, P J Schomberg, et al.Neurosurgery|January 23, 1999
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomasS V Rajkumar, J C Buckner, P J Schomberg, et al.Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.Pageof 545